Douglas Flora: Thrilled to Share The Launch Of The THRIVE Precision Wellness Clinic

Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared Jaime Grund’s post on LinkedIn, adding:

“Unlocking a New Era of Health: Prevention as the Ultimate Cure!

‘The doctor of the future will give no medicine but will instruct his patient in the care of the human frame, in diet, and the cause and prevention of disease.’ – Thomas A. Edison.

We are thrilled to share the launch of the THRIVE Precision Wellness Clinic, a groundbreaking initiative housed within the Center for Precision Medicine and Genomic Health at St. Elizabeth Healthcare!

A huge congratulations to Jaime Grund for her incredible leadership, and to the entire team for their profound vision in building this initiative to improve the health of our community. This momentous vision was cultivated over several years in collaboration with incredible forward-thinkers: Barry Wendt, Daniel Flora, and Brooke Holbrook, and our rockstar, Kate Pielage.

While genetic testing provides a crucial foundation for genomic-based care, it’s just one piece of the puzzle. THRIVE Precision Wellness brings the true meaning of precision medicine to life by intensely focusing on modifiable risk factors and lifestyle. This approach tailors prevention and treatment based on an individual’s unique genes, environment, and daily habits.

With the recent discussions at ASCO around colon cancer survival and the undeniable impact of diet and exercise, the timing for THRIVE couldn’t be more perfect. When the department was named the Center for Precision Medicine and Genomic HEALTH years ago, we knew this moment would come—and now it’s here.

THRIVE offers a comprehensive, personalized approach to disease prevention that extends far beyond the traditional model.

We address:

• Nutrition

• Physical activity

• Mental well-being

• Sleep health

• Insights from wearable devices and continuous glucose monitoring

What truly sets THRIVE apart is its intentional focus on helping each person understand their own health—both physically and emotionally—while identifying barriers and building sustainable habits aligned with their long-term goals. This is about empowerment and sustained well-being.

This is a true testament to innovation and dedication!”

Jaime Grund, Director of Precision Medicine and Breast Centers at St. Elizabeth Healthcare, shared a post on LinkedIn:

“I’m honored to share the launch of the THRIVE Precision Wellness Clinic, housed in the Center for Precision Medicine and Genomic Health at St. Elizabeth Healthcare. This vision was born a few years ago in collaboration with forward-thinkers such as Barry Wendt, Daniel Flora, and Brooke Holbrook. With the addition of Kaitlin Pielage to our team, that vision has come to fruition!

While genetic testing is a critical starting point for genomic-based care, it’s only part of the story. By focusing on modifiable risk factors and lifestyle, THRIVE Precision Wellness brings the true meaning of precision medicine to life – an approach that tailors prevention and treatment based on an individual’s genes, environment, and lifestyle.

With all the recent buzz around colon cancer survival and the impact of diet and exercise presented at ASCO just days ago, the timing could not be better. When our department was named the Center for Precision Medicine & Genomic HEALTH years ago, we knew this moment would come—and now it’s here.

THRIVE offers a comprehensive, personalized approach to disease prevention that goes far beyond the traditional model. We address:

• Nutrition

• Physical activity

• Mental well-being

• Sleep health

• Insights from wearable devices and continuous glucose monitoring

What sets THRIVE apart is its intentional focus on helping each person understand their own health, physically and emotionally, while identifying barriers and building sustainable habits aligned with their long-term goals.

Currently, the THRIVE Precision Wellness Clinic is limited to our existing Cancer Prevention Clinic patients (with an identified hereditary risk), with the goal of expanding to system-wide access across disease states throughout the remainder of 2025. Stay tuned for updates as we accommodate growing volumes.”

More posts featuring Douglas Flora.